UnknownPhase 4

Induction of Ovulation by Clomiphene Citrate Following Laparoscopic Surgery for Endometriosis Stage 1 and Stage 2 With and Without Suppression by Dienogest

Egypt310 participantsStarted 2014-10

Plain-language summary

This study aims at investigating the fertility outcome of endometriosis suppression with dienogest 2mg / day for 3 month followed by induction of ovulation for 3 month in endometriosis patients stage I and II.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Male factor.
✕. Other factors e.g. mullerian duct anomalies, hydrosalpinx.
✕. Age \> 35 years.
✕. Day 3 FSH \> 14 mlu/ml or antimullerian hormone \<1 ng/1.

What they're measuring

Clinical pregnancy rate

Timeframe: 2 months

Trial details

NCT IDNCT02575248

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-07

Contact for this trial

sherif Abdelhamid, professor

01001424742

View on ClinicalTrials.gov More Infertility trials